1. Home
  2. VANI vs GCV Comparison

VANI vs GCV Comparison

Compare VANI & GCV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vivani Medical Inc. (DE)

VANI

Vivani Medical Inc. (DE)

SELL

Current Price

$1.16

Market Cap

111.0M

Sector

Health Care

ML Signal

SELL

Logo Gabelli Convertible and Income Securities Fund Inc. (The)

GCV

Gabelli Convertible and Income Securities Fund Inc. (The)

SELL

Current Price

$4.04

Market Cap

92.5M

Sector

Finance

ML Signal

SELL

Company Overview

Basic Information
Metric
VANI
GCV
Founded
1998
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Finance/Investors Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
111.0M
92.5M
IPO Year
2014
1994

Fundamental Metrics

Financial Performance
Metric
VANI
GCV
Price
$1.16
$4.04
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
★ $3.83
N/A
AVG Volume (30 Days)
★ 153.0K
57.9K
Earning Date
11-12-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
★ N/A
Revenue
★ $4,000,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.92
$3.95
52 Week High
$1.92
$4.80

Technical Indicators

Market Signals
Indicator
VANI
GCV
Relative Strength Index (RSI) 37.37 33.08
Support Level $1.15 N/A
Resistance Level $1.25 $4.53
Average True Range (ATR) 0.04 0.08
MACD -0.00 -0.00
Stochastic Oscillator 4.32 30.53

Price Performance

Historical Comparison
VANI
GCV

About VANI Vivani Medical Inc. (DE)

Vivani Medical Inc is a clinical stage biopharmaceutical company which develops miniature, ultra long-acting subdermal drug implant candidates utilizing its proprietary NanoPortal technology, which is designed to enable reversible, ultra long-acting, near constant-rate delivery of a broad range of medicines to treat chronic diseases. Vivani uses this platform technology to develop, and potentially commercialize, drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the treatment of chronic diseases, including medication non-adherence, drug tolerability and administration challenges faced by certain patients. It operates in two segments the Biopharm Division and Neurostimulation Division.

About GCV Gabelli Convertible and Income Securities Fund Inc. (The)

GABELLI CONVERTIBLE & INCOME SECURITIES FUND INC is a diversified closed-end management investment company. Its investment objective is to seek a high level of total return through a combination of current income and capital appreciation by investing in convertible securities. The company invests in various portfolios such as Health Care, Financial Services, Real Estate Investment Trust, Energy and Utilities, Telecommunications, Food and Beverage, Aerospace and Automotive, and others. All the operation of the group is operated through the regions of the United States.

Share on Social Networks: